Accès ouvert
2025
article
OpenAlex
Valeria Durante, Benjamin Theek, Manuel Martinez-Osuna, Emmanuel Donnadieu et autres
Up until present day, chimeric antigen receptor (CAR)-T cell therapy has only been approved for hematological malignancies, as CAR-T cells do not show comparable efficacy in solid tumors. Therefore, understanding the features of the tumor microenvironment (TME), is key to improve efficacy …
de, fr
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Valeria Durante, Benjamin Theek, Manuel Martinez-Osuna, Emmanuel Donnadieu et autres
Up to date chimeric antigen receptor (CAR)-T cell therapy has been approved only for hematological malignancies, as CAR-T cells do not show comparable efficacy in solid tumors. Therefore, understanding the features of the tumor microenvironment (TME) is key to achieve improved efficacy …
Accès ouvert
2024
article
OpenAlex
Kübra Yadigaroglu, Sonja Scharf, Steffen Gretser, Hendrik Schäfer et autres
Although checkpoint molecules like CTLA-4 and PD1 have been described several years ago, checkpoint inhibitors such as nivolumab (an anti-PD-1 antibody) have only recently been used to treat classic Hodgkin lymphoma (cHL). Several studies have shown convincing therapeutic effects of nivolumab in …
de, fr
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Justine Perrin, Marisa Capitao, Mathilde Allard, Nicolas Chouin et autres
fr, de
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Elisa Peranzoni, Houcine Bougherara, Sarah Barrin, Audrey Mansuet‐Lupo et autres
CD8 T cell are key players in the fight against cancer. In order for CD8 T cells to kill tumor cells they need to enter into the tumor, migrate within the tumor microenvironment and respond adequately to tumor antigens. The recent development …
fr, gb
(code pays fourni par la source)
Accès ouvert
2011
article
OpenAlex
Hélène Salmon, Ana Rivas-Caicedo, François Asperti-Boursin, Camille Lebugle et autres
Naïve T cells continuously traffic to secondary lymphoid organs, including peripheral lymph nodes, to detect rare expressed antigens. The migration of T cells into lymph nodes is a complex process which involves both cellular and chemical factors including chemokines. Recently, the use …
fr
(code pays fourni par la source)